Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase IIa study of BIO-11006 shows reduced all-cause mortality from ARDS

April 24, 2020

In antibody ensemble, second fiddles help the neutralizing stars

April 24, 2020

NCS1 is a potential therapeutic target for Wolfram syndrome

April 24, 2020

Valneva and Dynavax collaborate on vaccine program for COVID-19

April 24, 2020

New approach generates biohybrid microswimmers with nanoerythrosome carriers

April 24, 2020

PTPN11 inhibitors presented by Gilead Sciences

April 24, 2020

Nippon Chemical Industrial describes new gold complexes for cancer

April 24, 2020

FORMA Therapeutics identifies USP30 inhibitors

April 24, 2020

Pfizer discloses new PDE4B inhibitors

April 24, 2020

Annapurna Bio patents apelin receptor agonists

April 24, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...